NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.

Featured Broker Partners


Advertisement